HealthQuill Health
Merck & Co. will acquire UK-based Verona Pharma Plc for about $10 billion to gain access to a respiratory drug approved by the US regulator, according to a statement from Merck.
Drugs Health Pharma

Merck to acquire Verona Pharma for $10 billion to net respiratory drug 

HQ Team July 9, 2025: Merck & Co. will acquire UK-based Verona Pharma Plc for about $10 billion and gain access to a.

Read More
A new and faster method of detecting and measuring radioactivity of tiny amounts of radioactive material has been developed by researchers at the National Institute of Standards and Technology (NIST), America’s national measurement institute.
Health Medical Research

NIST invents new technology to measure tiny radioactive material

HQ Team July 9, 2025: A new and faster method of detecting and measuring radioactivity of tiny amounts of radioactive material has been.

Read More
Novo Nordisk A/S has sought approval from the European Medicines Agency for a higher dose of its weight-loss drug Wegovy, after trial data showed a third of participants losing 25% of their body weight.
Drugs Health Pharma

Novo Nordisk seeks EU nod for higher dose of its weight-loss drug Wegovy

HQ Team July 8, 2025: Novo Nordisk A/S has sought approval from the European Medicines Agency for a higher dose of its weight-loss.

Read More
Novartis AG’s treatment for malaria in infants and newborns weighing between two and five kilograms has been approved in Switzerland, and eight African nations are set to follow.
Drugs Health Pharma

Novartis malaria drug for infants gets Swiss nod, 8 African nations in line

HQ Team July 8, 2025: Novartis AG’s treatment for malaria in infants and newborns weighing between two and five kilograms has been approved.

Read More
KalVista Pharmaceuticals Inc.'s medicine to treat hereditary angioedema, a rare disease that causes sudden and severe swelling attacks in the body, got approval from the US regulator. 
Drugs Health Pharma

KalVista’s oral pill for body swelling disorder gets US regulator’s nod 

HQ Team July 7, 2025: KalVista Pharmaceuticals Inc.’s medicine to treat hereditary angioedema, a rare disease that causes sudden and severe swelling attacks.

Read More
A new artificial intelligence model developed by researchers at Johns Hopkins University can predict whether a patient is likely to experience a cardiac arrest much better than doctors, who rely on limited clinical symptoms.
Health Medical Research

Doctors step aside, AI can predict patients at risk of cardiac arrest

HQ Team July 7, 2025: A new artificial intelligence model developed by researchers at Johns Hopkins University can predict whether patients are likely.

Read More
Scientists can tell how fast or gracefully you are ageing from a single magnetic resonance image of your brain, according to researchers at Duke University.
Health Medical Research

Duke researchers’ tool helps know how fast you are ageing, future diseases

HQ Team July 7, 2025: Scientists can tell how fast or gracefully you are ageing from a single magnetic resonance image of your.

Read More
A sponge-like material with long, microscopic air pockets that uses sunlight and a simple plastic cover can turn saltwater into freshwater, according to Chinese researchers.
Climate Health Research

Chinese researchers use aerogels, sunlight to desalinate seawater

HQ Team July 6, 2025: A sponge-like material with long, microscopic air pockets that uses sunlight and a simple plastic cover can turn.

Read More
Dog with a family
Health Opinion

Balancing work and companionship; choosing the right dog for your lifestyle

Alvina Miller July 2, 2025: In today’s fast-paced world, many people juggle demanding careers with personal aspirations for companionship and emotional connection. One.

Read More
Novartis AG’s end-stage trial of a drug to treat the inflammation of arteries, which affects people aged over 50 years, has failed to meet its primary goal of being symptom-free after a year of therapy.
Drugs Health Pharma

Novartis’ drug to treat inflammation of arteries fails in end-stage trials

HQ Team July 3, 2025: Novartis AG’s end-stage trial of a drug to treat the inflammation of arteries, which affects people aged over.

Read More